logo
Dr. Reddy's formulations facility in AP gets 7 U.S. FDA observations

Dr. Reddy's formulations facility in AP gets 7 U.S. FDA observations

The Hindu6 days ago
The U.S. Food and Drug Administration (U.S. FDA) has issued seven observations to Dr. Reddy's Laboratories after an inspection of the generic drugmaker's formulations manufacturing facility in Srikakulam, Andhra Pradesh.
'The U.S. FDA today completed a GMP and a pre-approval inspection (PAI) at our formulations manufacturing facility FTO 11 in Srikakulam, AP. The inspection was conducted from July 10-18. We have been issued a Form 483 with seven observations, which we will address within the stipulated timeline,' Dr. Reddy's said in a filing on Friday.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sensex, Nifty slip amid volatile trade triggered by stock-specific reactions
Sensex, Nifty slip amid volatile trade triggered by stock-specific reactions

New Indian Express

time25 minutes ago

  • New Indian Express

Sensex, Nifty slip amid volatile trade triggered by stock-specific reactions

CHENNAI: Indian equity markets ended in the red on Thursday, July 24, amid stock-specific volatility as investors weighed corporate earnings for the June quarter (Q1FY26). Benchmark indices were pressured by weak performances in IT, FMCG, and realty stocks, while select pharma and PSU bank counters offered some support. The BSE Sensex closed at 82,184.17, down 542.47 points or 0.66%, and the NSE Nifty50 settled at 25,062.10, declining 157.80 points or 0.63%. The session also marked the weekly F&O expiry, adding to the choppiness in trade. Key Gainers and Losers On the Sensex, top gainers included Zomato (Eternal), Tata Motors, Sun Pharma, Tata Steel, and Titan. While top laggards were Trent, Tech Mahindra, Bajaj Finserv, and Reliance Industries (RIL). The Nifty MidCap 100 index slipped 0.58%, while the Nifty SmallCap 100 index lost 1.09%, indicating broader market underperformance. Sectoral Performance Nifty IT declined 2.21%, reacting to earnings from firms like Infosys and Coforge. Nifty FMCG fell 1.12%, and Nifty Realty dropped 1.04%. While, Nifty PSU Bank rose 1.24%, supported by sustained buying interest. Nifty Pharma gained 0.55%, led by companies like Dr Reddy's Laboratories. Market Sentiment Investor sentiment remained cautious amid Q1 results season, with earnings from heavyweight companies such as Infosys, Dr Reddy's Labs, IEX, Coforge, and Tata Consumer Products being closely tracked. The volatility also reflected the derivatives expiry impact. According to analysts, markets are expected to remain stock-specific in the near term, driven by corporate earnings and global cues. Traders may keep a close watch on upcoming results from blue-chip companies, as well as movements in global markets, oil prices, and domestic macro indicators.

Edge data centre capacity in India likely to triple by 2027, says Icra
Edge data centre capacity in India likely to triple by 2027, says Icra

Business Standard

time35 minutes ago

  • Business Standard

Edge data centre capacity in India likely to triple by 2027, says Icra

India's edge data centre capacity is expected to expand significantly to 200-210 Megawatt (MW) by 2027, up from 60-70 MW in 2024, marking a 3x increase, driven by the proliferation of emerging technologies, said rating agency Icra. Global data centre capacity (including capacity held by cloud operators) is estimated at around 50 Gigawatt (GW) as of December 2024, of which about 10 per cent is edge data centres. The US commands over 44 per cent of worldwide edge data centre capacity, followed by Europe, the Middle East and Africa (EMEA) region at 32 per cent, and the Asia Pacific (APAC) region at 24 per cent. Edge data centres are smaller, decentralised facilities located closer to end-users and devices. Unlike traditional data centres, which are typically large and centralised, edge data centres enable real-time data processing with minimal latency (the delay between a user action and the corresponding system response). India is a relatively new entrant in the edge data centre market. The current edge data centre capacity as a percentage of total India's data centre capacity stands at around 5 per cent, said Icra. Further, excluding the edge data centre capacity used for captive purposes by one of the large data centre operators, the current edge data centre capacity as a percentage of total capacity is as low as 1 per cent. Anupama Reddy, Vice President and Co-Group Head, Corporate Ratings, Icra, said: 'In the Indian context, traditional data centres and edge data centres are complementary pillars of digital infrastructure. With the expanding cloud ecosystem of India, traditional data centres will continue fueling mass-scale computing, artificial intelligence (AI), and cloud workloads, and edge data centres will facilitate real-time processing and localised services. Traditional and edge data centres are expected to operate in the hub-and-spoke model to enhance efficiencies across sectors such as healthcare, banking, agriculture, defence, and manufacturing.' Despite the promising outlook, some of the key challenges for edge data centres include security vulnerabilities due to remote deployments (mainly in tier II and tier III cities), rapid technological changes that risk obsolescence, a shortage of skilled professionals in remote areas, and interoperability issues with traditional data centres. 'The rentals for edge data centres are anticipated to be on the higher side compared to traditional data centres, as they will be catering primarily to retail customers, compared to enterprise/hyperscale customers for traditional data centres. Moreover, the relatively higher capex cost per MW for edge data centres compared to a traditional data centre is expected to be compensated by higher rentals. Established data centre players and entities like RailTel and telecom operators are likely to lead the edge data centre expansion in India,' Reddy added.

Brigade Hotel IPO subscribed 48% on Day 1 so far: GMP hints at 9% listing pop
Brigade Hotel IPO subscribed 48% on Day 1 so far: GMP hints at 9% listing pop

Economic Times

time2 hours ago

  • Economic Times

Brigade Hotel IPO subscribed 48% on Day 1 so far: GMP hints at 9% listing pop

GMP of Brigade Hotel IPO IPO details Portfolio and growth plans Financials and valuation Live Events Analyst view (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel The Rs 759.6 crore initial public offering (IPO) of Brigade Hotel Ventures (BHVL), a hospitality arm of real estate major Brigade Enterprises , was subscribed 48% on the first day of bidding on Thursday, buoyed by strong interest from retail and non-institutional 2:36 pm on day 1, the retail tranche had been bid 1.94 times, while the non-institutional investor (NII) category saw 30% subscription. The quota for qualified institutional buyers (QIBs) received 8% the unofficial grey market, Brigade Hotel shares were trading at a premium of Rs 8 over the issue's upper price band of Rs 90, indicating a potential listing price of Rs 98 and an implied 8.9% IPO, comprising a fresh issue of 8.44 crore shares, is priced in a range of Rs 85–90 per share and will remain open until July 28. The stock is scheduled to debut on both BSE and NSE on July operates nine upscale hotels with 1,604 rooms across key South Indian cities, including Bengaluru, Chennai, Kochi, and Mysuru, as well as GIFT City in Gujarat. These properties are managed under marquee hospitality brands such as Marriott, Accor, and company posted an average occupancy rate of 76.8% in FY25, well above the industry average of 64.5%. BHVL aims to expand its portfolio to 14 hotels with 2,560 keys by FY29, with upcoming projects including a Grand Hyatt in Chennai and a Ritz-Carlton wellness resort in grew from Rs 350 crore in FY23 to Rs 468 crore in FY25, supported by a strong operating performance, with EBITDA margins holding at 35%. However, net profit slipped to Rs 23.7 crore in FY25 from Rs 31 crore the previous year, while return ratios remain the top end of the price band, the issue is valued at a price-to-earnings (P/E) multiple of 125x and a price-to-book (P/B) of 32.3x — levels that outstrip peers such as Lemon Tree Hotels and Indian Hotels remain divided. Ventura Securities has issued a 'Subscribe' rating, citing the company's premium asset base and strong brand partnerships, while Canara Bank Securities has cautioned about steep valuations, suggesting only long-term investors consider the its strategic presence in South India, premium affiliations, and expansion pipeline, BHVL is well-positioned to ride India's hospitality upcycle. Yet, the subdued grey market premium of 9% and the lofty valuation metrics suggest limited near-term listing gains.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store